查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1649461

精準醫療軟體市場預測（2025-2030）

Precision Medicine Software Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

精準醫療軟體市場規模預計將從 2025 年的 20.13 億美元增至 2030 年的 31.86 億美元，複合年成長率為 9.62%。

精準醫療，也稱為個人化醫療，是一種針對疾病預防和治療的客製化方法。它專注於預測疾病的易感性並預防疾病進展，減少藥物處方中的試驗並最大限度地減少副作用。精準醫療軟體作為技術平台，為患者提供資料驅動的個人化治療。全球癌症發生率的上升是預測期內推動精準醫療軟體市場成長的關鍵因素。精準醫療透過提供患者個人化治療在癌症治療上有著重要的應用。此外，人工智慧（AI）在醫療保健領域的日益融入也是推動精準醫療軟體需求的主要因素。世界各國都在實施重大政策和策略，以加強人工智慧在醫療保健領域的發展和融合。

精準醫療軟體市場促進因素：

  • 全球人工智慧技術的進步：人工智慧技術的快速進步是推動精準醫療軟體市場擴張的主要因素。在技​​術創新的推動下，人工智慧技術領域正在經歷顯著成長。美國、加拿大、印度等國家政府都推出了各種政策和舉措來促進人工智慧的發展，尤其是在醫療保健領域。

例如，2024年9月，印度衛生與家庭福利部宣布與印度理工學院坎普爾分校和國家衛生服務局合作，為醫療保健領域的人工智慧應用開發數位公共產品。同樣，2024 年 4 月，英國藥品和保健品管理局 (MHRA) 發布了將人工智慧融入醫療保健的策略方針。

影響精準醫療軟體市場的地理趨勢：

  • 北美顯著成長：預計預測期內北美地區將佔據精準醫療軟體市場的大部分佔有率。美國和加拿大等國家正在實施重大策略，將人工智慧納入其醫療保健系統。癌症等慢性病的發生率不斷上升，將進一步推動精準醫療技術的需求。

焦慮、憂鬱症和創傷後壓力症候群等精神疾病的發生率日益上升，迫切需要有效的治療方案。新冠疫情加劇了這些挑戰，並導致對心理健康服務的需求激增，因為人們在壓力和不確定性增加的情況下尋求幫助。總之，由於人工智慧技術的進步、全球對慢性病有效治療方法的需求不斷成長、政府鼓勵醫療技術創新的支持性政策以及有利的地理趨勢（尤其是北美），市場格局預計將大幅成長，從而加強了這一不斷擴大的市場環境。

為什麼要購買這份報告？

  • 深刻分析：獲得深入的市場洞察，涵蓋主要和新興地區，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途？

產業與市場分析、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略與市場佔有率分析
  • 各地區（包括細分市場和國家）的收益成長和預測分析
  • 公司概況（策略、產品、財務、主要發展等）

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第 5 章 精準醫療軟體市場（依部署）

  • 介紹
  • 雲
  • 本地

第6章 精準醫療軟體市場（依應用）

  • 介紹
  • 腫瘤學
  • 中樞神經系統
  • 免疫學
  • 心血管
  • 其他

第 7 章 精準醫療軟體市場（依最終用戶分類）

  • 介紹
  • 醫院和診所
  • 藥物研究設施
  • 其他

第 8 章 精準醫療軟體市場（按地區）

  • 介紹
  • 北美洲
    • 按部署
    • 按應用
    • 按最終用戶
    • 按國家
  • 南美洲
    • 按部署
    • 按應用
    • 按最終用戶
    • 按國家
  • 歐洲
    • 按部署
    • 按應用
    • 按最終用戶
    • 按國家
  • 中東和非洲
    • 按部署
    • 按應用
    • 按最終用戶
    • 按國家
  • 亞太地區
    • 按部署
    • 按應用
    • 按最終用戶
    • 按國家

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第10章 公司簡介

  • Accenture
  • Wipro
  • Intel
  • GenomOncology LLC
  • Precision Medicine Group, LLC.
  • Tempus
  • Genomind
  • Syapse Holdings, Inc.
  • Foundation Medicine, Inc.
  • 2bPrecise
  • Koninklijke Philips NV
  • Cision US Inc.
  • Genedata AG
  • Ariel Precision Medicine
  • Integrate.AI Inc.
簡介目錄
Product Code: KSI061617237

The precision medicine software market is estimated to grow at a CAGR of 9.62%, attaining US$3.186 billion by 2030, from US$2.013 billion in 2025.

Precision medicine is a tailored approach to disease prevention and treatment, also known as personalized medicine. It focuses on predicting susceptibility to diseases and preventing disease progression, reducing the trial-and-error nature of drug prescribing and minimizing adverse drug reactions. Precision medicine software serves as a technological platform that provides data-driven, personalized treatment for patients. The rising global incidence of cancer is a significant factor driving the growth of the precision medicine software market during the forecast period.Precision medicine has crucial applications in cancer treatment by offering personalized therapies to patients. Additionally, the increasing integration of artificial intelligence (AI) into healthcare is another major driver of demand for precision medicine software. Countries worldwide are implementing key policies and strategies to enhance the development and integration of AI within the healthcare sector.

Drivers of the Precision Medicine Software Market:

  • Advancements in Global AI Technology: The rapid advancement of artificial intelligence technologies is a primary factor fueling the expansion of the precision medicine software market. The AI technology sector has seen substantial growth, driven by innovations in technology. Governments in countries such as the USA, Canada, and India have introduced various policies and initiatives to promote AI development, particularly in healthcare.

For instance, in September 2024, India's Ministry of Health and Family Welfare announced a collaboration with IIT Kanpur and the National Health Authority to develop digital public goods for AI applications in healthcare. Similarly, in April 2024, the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) released its strategic approach to integrating AI into healthcare.

Geographical Trends Shaping the Precision Medicine Software Market:

  • Significant Growth in North America: The North American region is expected to hold a substantial share of the precision medicine software market during the forecast period. Countries like the USA and Canada have implemented key strategies to incorporate artificial intelligence into their healthcare systems. The increasing prevalence of chronic diseases, including cancer, further drives demand for precision medicine technologies.

The growing incidence of mental health disorders such as anxiety, depression, and PTSD has created an urgent need for effective treatment options. The COVID-19 pandemic exacerbated these challenges, leading to a surge in demand for mental health services as individuals sought help during heightened stress and uncertainty.In summary, the precision medicine software market is poised for significant growth driven by advancements in AI technology, rising global demand for effective treatments for chronic diseases, supportive governmental initiatives promoting innovation in healthcare technologies, and favorable geographical trends-particularly within North America-that enhance this expanding market landscape.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Precision Medicine Software Market is segmented and analyzed as follows:

By Deployment

  • Cloud
  • On-Premise

By Application

  • Oncology
  • Central Nervous System
  • Immunology
  • Cardiovascular
  • Others

By End User

  • Hospitals and Clinics
  • Pharmaceutical Research Institute
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • Spain
  • United Kingdom
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • Australia
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. PRECISION MEDICINE SOFTWARE MARKET BY DEPLOYMENT

  • 5.1. Introduction
  • 5.2. Cloud
  • 5.3. On-Premise

6. PRECISION MEDICINE SOFTWARE MARKET BY APPLICATIONS

  • 6.1. Introduction
  • 6.2. Oncology
  • 6.3. Central Nervous System
  • 6.4. Immunology
  • 6.5. Cardiovascular
  • 6.6. Others

7. PRECISION MEDICINE SOFTWARE MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Pharmaceutical Research Institute
  • 7.4. Others

8. PRECISION MEDICINE SOFTWARE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Deployment
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Deployment
    • 8.3.2. By Application
    • 8.3.3. By End User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Deployment
    • 8.4.2. By Application
    • 8.4.3. By End User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. Spain
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. France
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Deployment
    • 8.5.2. By Application
    • 8.5.3. By End User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. South Africa
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Deployment
    • 8.6.2. By Application
    • 8.6.3. By End User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. Australia
      • 8.6.4.4. India
      • 8.6.4.5. South Korea
      • 8.6.4.6. Indonesia
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Accenture
  • 10.2. Wipro
  • 10.3. Intel
  • 10.4. GenomOncology LLC
  • 10.5. Precision Medicine Group, LLC.
  • 10.6. Tempus
  • 10.7. Genomind
  • 10.8. Syapse Holdings, Inc.
  • 10.9. Foundation Medicine, Inc.
  • 10.10. 2bPrecise
  • 10.11. Koninklijke Philips N.V
  • 10.12. Cision US Inc.
  • 10.13. Genedata AG
  • 10.14. Ariel Precision Medicine
  • 10.15. Integrate.AI Inc.